Prevest Denpro's credibility gap: 3D printer launch date shifted 19 months without explanation
CEO claimed in June 2026 sales began Nov 2024, but had said in May 2025 the printer was not yet commercial. The contradiction muddies a solid annual result.
The numbers
- FY26 revenue crossed ₹71 crore with margins at 38.6%, and digital dentistry revenue surged ~40%.
- US private-label business grew 37.58%, but Q4 revenue growth slowed to just 2.63%.
- Capacity utilization on new digital lines is only 18-20%, leaving headroom of ~₹125 crore at full capacity.
- OraDoc segment declined 2% YoY due to MoCRA delays and Dubai disruptions.
Management's story
- Management touts digital dentistry as the primary growth engine, with 3D printer and resin revenue up ~40%.
- CEO Dr. Sai Kalyan claimed 3D printer sales began in November 2024, setting a base for 162% growth.
- Guidance targets an indigenous 3D printer by 2028 and expects digital workflows to drive 40% of dental procedures within 5 years.
- Full facility capacity is pegged at ~₹125 crore revenue, nearly double the current run rate, but no timeline given.
“We started selling 3D printers in November 2024.”
— Dr. Sai Kalyan, CEO, Jun 2026 call
Where they diverge
The numbers are solid: annual growth, strong margins, and a 92-country export reach. But management's timeline for the 3D printer, billed as the next growth driver, shifted by 18 months between two calls. In May 2025, the CEO said the printer was not yet commercial. In June 2026, he claimed sales started in November 2024. No explanation was offered. That gap undermines trust in the growth narrative, even if the underlying business remains sound.
The full read
Prevest Denpro delivered a solid annual result: revenue crossed ₹71 crore, margins held at 38.6%, and digital dentistry surged ~40%. The export story is intact, with private-label US sales up 37.58% and a 92-country reach. But the quarter that matters is the one management cannot keep straight. In May 2025, CEO Dr. Sai Kalyan told investors the 3D printer was 'very soon' and not yet commercial, with only sample pieces in the market. Thirteen months later, he claimed the company started selling 3D printers in November 2024, a retroactive shift of 18 months. The 162% sales growth he cited uses that new base, not the one investors were led to expect. This contradiction is not about numbers. It is about credibility. The underlying business has real strengths: low utilization (18-20%) on new digital lines offers a long runway, and full capacity of ~₹125 crore is nearly double current revenue. But a strategy pivot that is not acknowledged erodes trust. Investors should demand a clear explanation of when the 3D printer actually launched and why the story changed. Until then, the growth narrative rests on a shaky timeline.
What we're watching
- 3D printer revenue contribution in the next two quarters: will the claimed base hold?
- Timeline for new products (disinfectants, endodontic files) and their commercialization.
- OraDoc recovery post-MoCRA and Dubai disruptions; online sales scale remains unknown.
- Capacity utilization on digital lines: a ramp from 18-20% would signal execution.